Method for in vivo targeting of nanoparticles via bioorthogonal copper-free click chemistry
The present disclosure relates to a method for in vivo targeting of a nanoparticle via bioorthogonal copper-free click chemistry, more particularly to a method for in vivo targeting of a nanoparticle, including: injecting a precursor capable of being metabolically engineered in vivo when injected into a living system and having a first bioorthogonal functional group into the living system; and injecting a nanoparticle having a second bioorthogonal functional group which can perform a bioorthogonal copper-free click reaction with the first bioorthogonal functional group attached thereto into the living system. In accordance with the present disclosure, accumulation of nanoparticles at a target site in a living system can be increased remarkably and the biodistribution of the nanoparticles can be controlled since the nanoparticles bound to a cell surface are taken up into the cell with time.
1. A method for in vivo targeting of a nanoparticle, comprising:
injecting tetraacetylated N-azidoacetyl-D-mannosamine (Ac 4 ManNAz) at a concentration of at least 50 mM intratumorally to tumors of a living system; and
intravenously injecting dibenzylcyclooctyne (DBCO)-functionalized liposome into the living system.
2. The method for in vivo targeting of a nanoparticle according to claim 1 , wherein the nanoparticle has a size of 10-1000 nm such that in vivo circulation is possible.
3. The method for in vivo targeting of a nanoparticle according to claim 1 , wherein the nanoparticle is an organic nanoparticle, an inorganic nanoparticle or an organic-inorganic hybrid nanoparticle.
4. The method for in vivo targeting of a nanoparticle according to claim 3 , wherein the organic nanoparticle is selected from the group consisting of liposome, micelle, polymer carrier and protein nanoparticles and the A inorganic nanoparticle is selected from the group consisting of gold and silica nanoparticles.